emocha Mobile Health, a Baltimore-based startup company focused on medication adherence, today announced that it has been awarded a Small Business Innovation Research award by the National Institute on Drug Abuse (NIDA). Through the NIH Fast-Track mechanism, the Phase 1 award will total $225,000, with an additional $1.5 million for Phase 2 granted upon achieving milestones. The project will demonstrate the feasibility of video directly observed therapy for patients undergoing the initiation phase of buprenorphine treatment through office-based opioid treatment (OBOT) programs. Outcomes of interest will include adherence, retention in care, measures of illicit opioid use and abstinence, and medication diversi